pegaspargase 2500 IU/m2 x 1 clinical trials

A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents

This study looks at how best to give a medicine called pegaspargase to children and young people with acute lymphoblastic leukaemia (ALL). It compares different ways of giving the medicine, aiming to find the most effective and safest approach to help treat this type of blood cancer.